packagePralsetinib

pralsetinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pralsetinib is a protein kinase inhibitor used to treat non-small-cell lung cancer. Its marketing authorisation in the European Union has been withdrawn, though it remains approved elsewhere.

Summary written by glm-5.3-flash from Wikidata Q97732199 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:pralsetinib
ATC codes:L01EX23
DrugBank:DB15822
PubChem CID:129073603
Wikidata:Q97732199
formula:C27H32FN9O2
molar mass:533.612 g/mol (PubChem CID 129073603)
logP:3.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown